How can controlled human infection models accelerate clinical development and policy pathways for vaccines against Shigella? (2019)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2019.03.036

PubMed Identifier: 31358238

Publication URI: http://europepmc.org/abstract/MED/31358238

Type: Journal Article/Review

Volume: 37

Parent Publication: Vaccine

Issue: 34

ISSN: 0264-410X